NEW YORK (GenomeWeb) – Resolution Bioscience said today that it is collaborating with Janssen to develop its Resolution HRD liquid biopsy test as a companion diagnostic for niraparib, a PARP inhibitor being investigated to treat patients with metastatic castration-resistant prostate cancer.